Unlocking the QSBS Advantage: 2026 Update to Section 1202 Planning Guide   

Recent legislative changes have significantly expanded the economic impact of Qualified Small Business Stock (QSBS) for stock issued on or after July 4, 2025. While Section 1202 has existed for decades, the post‑2025 regime introduces greater flexibility, higher exclusion limits, and broader issuer eligibility, while materially increasing complexity, documentation requirements, and audit risk.  

What Changed: The Post‑July 4, 2025 QSBS Regime 

For stock issued after July 4, 2025, Congress fundamentally expanded the economic usefulness of QSBS through the One Big Beautiful Bill Act (OBBBA). These changes do not replace prior law; instead, they create a dual‑track regime in which eligibility and benefits depend on the precise issuance date of each tranche of stock. 

The most consequential updates include a shift away from an all‑or‑nothing holding‑period rule, a higher per‑issuer exclusion cap, and a higher gross‑asset ceiling for issuing corporations. 

1. QSBS is no longer all-or-nothing on timing
   Prior law: No exclusion unless stock was held more than five years.New law: QSBS issued on or after July 4, 2025 qualifies for graduated exclusions: 
   • 50% exclusion after 3 years 
   • 75% exclusion after 4 years 
   • 100% exclusion after 5 yearsThis fundamentally changes exit and liquidity planning by allowing earlier monetization with meaningful tax benefits.
     
2. Exclusion caps are meaningfully higherPrior law: Lifetime exclusion capped at the greater of $10 million or 10× basis.

   New law: For post-July 4, 2025 stock, the cap increases to the greater of $15 million or 10× basis, with the $15 million amount indexed for inflation beginning in 2027.

   For larger exits, this amplifies the importance of basis support and valuation at issuance.
   

3. More companies can qualify but with more scrutinyPrior law: Issuer gross assets limited to $50 million.

   New law: Threshold increases to $75 million for post-2025 issuances, also indexed for inflation.

   This allows later-stage and better-capitalized companies to issue QSBS, but heightens valuation sensitivity where assets, IP, or prior entities are contributed. 

QSBS eligibility and benefits now depend on issuance date, meaning companies and shareholders may hold multiple tranches of stock governed by different rules. This creates planning opportunities and traps that did not previously exist. 

Shorter holding periods, larger exclusions, and more frequent QSBS claims make valuation, conversion mechanics, and documentation central audit targets. Independent, contemporaneous valuations are increasingly defensive infrastructure rather than optional diligence. 

Core Eligibility Requirements 

QSBS eligibility still turns on three pillars: issuer qualification, original issuance, and holding period compliance. 

Issuer qualification requires that the company: 

• Be a U.S. C‑corporation
• Have aggregate gross assets not exceeding the applicable threshold ($50M pre‑2025; $75M post‑2025) immediately before and after issuance; 
• Conduct a qualified trade or business (excluding most professional services, finance, real estate, hospitality, and similar fields); 
• Use at least 80 percent of its assets in the active conduct of that business for substantially all of the holding period. 

Original issuance means the stock must be acquired directly from the company, in exchange for cash, property (other than stock), or services. Secondary purchases generally do not qualify. 

Holding period requirements depend on issuance date. Pre‑2025 stock generally requires a full five‑year hold for any exclusion. Post‑2025 stock qualifies for partial or full exclusion beginning at year three. 

Why Valuation Determines QSBS Eligibility 

Valuation is central to QSBS eligibility because Section 1202 requirements are tested at discrete points in time, not at exit. The most consequential of these moments, such as formation, conversion to C-corporation status, and stock issuance, often occur years before liquidity, yet the valuation conclusions reached then can permanently determine whether QSBS benefits are available at all. 

The gross-asset test is applied immediately before and after issuance using tax basis, with contributed property, including intellectual property, generally treated as held at fair market value. An overstated valuation can cause a company to exceed the applicable asset threshold and disqualify QSBS entirely. Conversely, an understated valuation can suppress shareholder basis, materially limiting the availability of the 10× basis exclusion in a successful exit. In either case, valuation errors compound over time and are rarely correctable 

Valuation also establishes the factual foundation for original issuance, capitalization integrity, and conversion mechanics. These facts are difficult to reconstruct once a company has scaled or approached liquidity, particularly under heightened IRS scrutiny. As post-2025 legislative changes increase exclusion amounts and shorten effective holding periods, valuation has become a primary focus of QSBS enforcement. 

For founders and investors, valuation should be treated as planning infrastructure rather than compliance. Independent, contemporaneous valuations align tax, legal, and capitalization decisions when flexibility still exists. In QSBS planning, valuation does not merely support eligibility, it defines it. 

Common Valuation Failures 

QSBS eligibility is most often lost not through aggressive tax planning, but through routine valuation missteps made early in a company’s lifecycle. These failures frequently remain hidden until a financing or exit, when they are difficult, or impossible, to correct. 

One common failure is relying on informal or non-tax valuations at formation or conversion. Financial statement valuations, internal estimates, or investor-driven pricing are often misapplied to Section 1202 analyses, despite being prepared for different purposes and under different standards. When these values are later used to support the gross-asset test or shareholder basis, the underlying assumptions and methodologies may not align with the standards relevant to Section 1202. 

Another frequent issue arises in entity conversions. In response to expanded QSBS benefits, many LLCs and S-corporations convert to C-corporation status without a contemporaneous valuation that explicitly addresses asset basis, contributed property, and sequencing of legal steps. Stock issued before conversion is fully effective, or before assets are properly measured, may be permanently disqualified from QSBS treatment. 

Valuation failures also occur when intellectual property or other contributed assets are inadequately analyzed. Overstated asset values can push a company over the applicable gross-asset threshold, while understated values can materially reduce future exclusion capacity under the 10× basis limitation. 

Finally, attempts to retroactively reconstruct valuations at financing or exit introduce significant audit risk. As QSBS claims grow larger and holding periods shorten under post-2025 law, contemporaneous, independent valuation has become essential. In QSBS planning, valuation errors rarely announce themselves early—but they are decisive when it matters most. 

How Proper Valuation Protects QSBS 

Proper valuation is the primary safeguard of QSBS eligibility because it creates a defensible record at the moments when Section 1202 requirements are tested. Independent, contemporaneous valuations establish support for the gross-asset test, shareholder basis, and original issuance, elements that cannot be reliably reconstructed once a company has scaled or approached liquidity. 

A well-supported valuation helps ensure that contributed assets, including intellectual property, are measured appropriately for tax purposes, reducing the risk that a company inadvertently exceeds the applicable gross-asset threshold at issuance. At the shareholder level, accurate valuation supports tax basis, which directly affects the availability of the 10× basis exclusion in larger exits. In both cases, valuation discipline preserves upside by preventing technical disqualification or silent erosion of exclusion capacity. 

Proper valuation also provides critical audit defense. As QSBS claims increase in size and are realized earlier under post-2025 law, IRS scrutiny is increasingly focused on valuation assumptions, methodologies, and contemporaneous documentation. Third-party valuations prepared with explicit Section 1202 considerations serve as objective evidence of compliance, strengthening credibility and reducing the risk of adverse recharacterization. 

Working with a specialized valuation partner further strengthens this protection. Houlihan Capital approaches QSBS-related valuations with the understanding that Section 1202 analysis is not a generic fair market value exercise, but a tax-sensitive engagement requiring coordination across legal, tax, and capitalization frameworks. Valuations are structured to explicitly address the gross-asset test immediately before and after issuance, the treatment of contributed property at fair market value for tax purposes, and the documentation necessary to support original issuance and shareholder basis. 

Houlihan Capital’s methodology typically integrates multiple valuation approaches, including income, market, and asset-based analyses, calibrated to the company’s stage of development and the specific triggering event (formation, conversion, equity issuance, or restructuring). 

Ultimately, valuation protects QSBS by aligning tax, legal, and financial decisions when flexibility still exists. When performed with Section 1202 specifically in mind and supported by rigorous methodology and documentation, valuation becomes not merely a compliance exercise, but the infrastructure that preserves the benefit itself. 

Conclusion 

QSBS benefits are determined long before exit and are rarely recoverable once lost. Founders, investors, and early employees should evaluate QSBS eligibility at formation, conversion, and issuance, supported by defensible, independent valuation. Early coordination across tax, legal, and valuation advisors is essential to preserving eligibility, maximizing exclusion potential, and reducing audit risk under the post-2025 regime.  

To discuss QSBS valuation needs specific to your company's situation, contact: